These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1192354)

  • 1. Comparison of serum concentrations of methotrexate after various routes of administration.
    Freeman-Narrod M; Gerstley BJ; Engstrom PF; Bornstein RS
    Cancer; 1975 Nov; 36(5):1619-24. PubMed ID: 1192354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in erythrocytes of patients with psoriasis.
    Schrøder H; Foged EK
    Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of solid tumors using high-dose methotrexate and citrovorum factor].
    Baumgartner G; Heinz R; Karrer K; Pridun N; Lutz D
    Osterr Z Onkol; 1977; 3(5-6):141-8. PubMed ID: 300863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours.
    Christophidis N; Vajda FJ; Lucas I; Moon WJ; Louis WJ
    Br Med J; 1979 Feb; 1(6159):298-300. PubMed ID: 421088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose methotrexate kinetics in arthritis.
    Edelman J; Biggs DF; Jamali F; Russell AS
    Clin Pharmacol Ther; 1984 Mar; 35(3):382-6. PubMed ID: 6697645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.
    Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A
    Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation and enhancement of serum methotrexate concentrations by probenecid.
    Aherne GW; Piall E; Marks V; Mould G; White WF
    Br Med J; 1978 Apr; 1(6120):1097-9. PubMed ID: 638616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid.
    Lilly MB; Omura GA
    Cancer Chemother Pharmacol; 1985; 15(3):220-2. PubMed ID: 3902265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of an easily prepared solution of injectable methotrexate diluted in water: A comparison of serum concentrations vs methotrexate tablets and clinical utility.
    Marshall PS; Gertner E
    J Rheumatol; 1996 Mar; 23(3):455-8. PubMed ID: 8832982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate bioavailability after oral and intramuscular administration in children.
    Teresi ME; Crom WR; Choi KE; Mirro J; Evans WE
    J Pediatr; 1987 May; 110(5):788-92. PubMed ID: 3471936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
    Pitman SW; Frei E
    Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patients.
    Reggev A; Djerassi I
    Cancer; 1988 Jun; 61(12):2423-8. PubMed ID: 3259154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compared bioavailability of methotrexate administered orally or intramuscularly in rheumatoid arthritis].
    Auvinet B; Jarrier I; Le Levier F; Pegon Y; Turcant A; Allain P
    Presse Med; 1992 May 2-9; 21(17):822. PubMed ID: 1535146
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study.
    Frankel LS; Wang YM; Shuster J; Nitschke R; Doering EJ; Pullen J
    J Clin Oncol; 1983 Dec; 1(12):804-9. PubMed ID: 6583318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
    Pearson AD; Amineddine HA; Yule M; Mills S; Long DR; Craft AW; Chessells JM
    Br J Cancer; 1991 Jul; 64(1):169-73. PubMed ID: 1854617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.